BASEL, Switzerland

Mirjam Zimmermann

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignees: Interax Biotech Ag, Paul Scherrer Institut. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mirjam Zimmermann. Retrieved from https://idiyas.com/inventor/mirjam-zimmermann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mirjam Zimmermann: Innovator in Biotech

Introduction

Mirjam Zimmermann is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of biotechnology, particularly through her innovative work on beta-arrestin mutants. With a strong academic and professional background, she has established herself as a key figure in her area of expertise.

Latest Patents

Mirjam holds a patent for her work on beta-arrestin mutants, showcasing her ability to innovate and contribute to scientific advancements. This patent represents her commitment to pushing the boundaries of knowledge in biotechnology. She has 1 patent to her name, reflecting her dedication to research and development.

Career Highlights

Throughout her career, Mirjam has worked with esteemed organizations such as the Paul Scherrer Institut and Interax Biotech AG. These experiences have allowed her to collaborate with leading experts in the field and further her research initiatives. Her work has been instrumental in advancing the understanding of beta-arrestin and its applications.

Collaborations

Mirjam has collaborated with notable colleagues, including Benoit Meger and Martin Konrad Ostermaier. These partnerships have enriched her research and contributed to the success of her projects.

Conclusion

Mirjam Zimmermann is a trailblazer in the biotechnology sector, with a focus on beta-arrestin mutants. Her innovative spirit and collaborative efforts have positioned her as a significant contributor to scientific research. Her work continues to inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…